Particularities of IBD Trials in Children

Area of Science:

• Pediatric Gastroenterology
• Clinical Trial Design
• Pharmacology

Background:

• Pediatric inflammatory bowel diseases (IBD) require high-quality clinical trials similar to adult IBD.
• Recruiting pediatric patients for clinical trials is more challenging than for adults.
• Delayed pediatric drug approval leads to off-label use and complicates future trials.

Purpose of the Study:

• To review and propose solutions for age-specific challenges in pediatric IBD clinical trials.
• To facilitate more efficient pediatric drug development for IBD.

Main Methods:

• Review of existing challenges and proposed solutions for pediatric IBD trials.
• Discussion of extrapolation of efficacy from adult trials.
• Emphasis on pharmacokinetics/pharmacodynamics (PK/PD) similarity studies.
• Consideration of non-invasive activity scores and biomarkers.
• Strategies to avoid placebo use and ensure treatment equipoise.

Main Results:

• Extrapolation of adult efficacy is feasible if PK/PD studies show similarity.
• Pediatric trials can focus on dosing and safety, potentially avoiding placebo.
• Non-invasive measures and biomarkers aid in feasibility.
• Including adolescents in adult trials presents both benefits and drawbacks.

Conclusions:

• Addressing age-specific challenges is crucial for successful pediatric IBD drug development.
• Extrapolation, PK/PD studies, and careful trial design can overcome recruitment and ethical hurdles.
• Focusing on safety and dosing while ensuring effective treatment is key.